XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.2
Going Concern, Significant Risks and Uncertainties (Tables)
6 Months Ended
Jun. 30, 2023
Going Concern, Significant Risks and Uncertainties  
Schedule of revenue channels accounted for 10% or more of the Company's net sales

 


Three months ended June 30,

Six months ended June 30,



 


2023

2022

2023

2022

Revenue channel:














Rx gammaCore - VA/DoD


58.6 %
55.1 %
59.8 %
60.4 %

National Health Service


9.8 %
16.4 %
9.9 %
15.3 %